1. Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells. Issue 6 (10th June 2022) Authors: He, Mi; Soni, Bhavesh; Schwalie, Petra C; Hüsser, Tamara; Waltzinger, Caroline; De Silva, Duvini; Prinz, Ylva; Krümpelmann, Laura; Calabro, Samuele; Matos, Ines; Trumpfheller, Christine; Bacac, Marina; Umaña, Pablo; Levesque, Mitchell P; Dummer, Reinhard; van den Broek, Maries; Gasser, Stephan Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗